Table 3.
Main and Interaction Effects of Recovery at Baseline on Well-being, Flourishing, and Languishing at 6-Month Postbaseline
| Well-being | Flourishing | Languishing | ||||||
|---|---|---|---|---|---|---|---|---|
| β | ∆R2 | OR | 95% CI for OR | OR | 95% CI for OR | |||
| Lower | Upper | Lower | Upper | |||||
| Step 1 (Clinical and functional recovery) | .12 | |||||||
| Positive symptoms of schizophrenia (SAPS) | −.15 | .56* | .35 | .91 | .73 | .41 | 1.29 | |
| Negative symptoms of schizophrenia (SANS) | −.20* | 1.01 | .64 | 1.58 | 1.90* | 1.06 | 3.40 | |
| Social and occupational functioning (SOFAS) | .09 | 1.20 | .76 | 1.88 | .88 | .47 | 1.64 | |
| Daily functioning (UPSA-B) | .08 | 1.11 | .73 | 1.68 | .90 | .53 | 1.53 | |
| Step 2 (Personal recovery) | .26 | |||||||
| Personal recovery (RAS) | .55*** | 1.58* | 1.02 | 2.45 | .31** | .15 | .65 | |
| Step 3 (Interaction: personal recovery × clinical recovery, personal recovery × functional recovery) | .01 | |||||||
| RAS × SAPS | −.04 | 1.16 | .77 | 1.74 | 1.30 | .64 | 2.63 | |
| RAS × SANS | .01 | 1.10 | .63 | 1.90 | .98 | .38 | 2.51 | |
| RAS × SOFAS | .01 | .86 | .50 | 1.46 | 1.03 | .40 | 2.66 | |
| RAS × UPSA-B | .08 | 1.34 | .77 | 2.30 | .78 | .37 | 1.63 | |
* P < .05, ** P < .01, *** P < .001